Research & Insights
Finch Capital publishes research on critical technology for Europe's regulated industries and functions
Retreat from telemedicine is driving innovation across healthcare as technology value has become clear

The 2022 State of European HealthTech Report examines how the healthcare technology landscape evolved following the pandemic-driven boom, with a particular focus on the post-telemedicine innovation wave.
After experiencing unprecedented growth during the COVID-19 pandemic, telemedicine saw a natural retreat as in-person healthcare services resumed. However, this retreat revealed the true value of digital health technologies and sparked innovation in more sustainable and integrated solutions.
Healthcare providers began seeking comprehensive platforms that could seamlessly integrate virtual and in-person care, leading to innovation in hybrid care delivery models and patient management systems.
The proven value of technology during the pandemic accelerated adoption of AI-powered diagnostic tools, particularly in radiology, pathology, and drug discovery applications.
Beyond simple consultation platforms, the market saw growth in evidence-based digital therapeutic solutions that could deliver measurable health outcomes, particularly in mental health and chronic disease management.
European regulators began providing clearer frameworks for digital health solutions, enabling more predictable paths to market for innovative healthcare technologies.
Healthcare systems across Europe began developing sustainable reimbursement models for digital health solutions, moving beyond emergency pandemic measures to long-term integration strategies.
The pandemic period demonstrated clear evidence of technology's value in healthcare delivery, leading to sustained investment and adoption across European healthcare systems. This recognition created a foundation for continued innovation and integration.
The HealthTech sector emerged from 2022 with a more mature understanding of where digital solutions provide the greatest value, setting the stage for sustainable growth and meaningful healthcare improvements across Europe.
This research was conducted by Finch Capital as part of our comprehensive analysis of European healthcare technology markets.